Vocabria 600 mg prolonged-release suspension for injection, REKAMBYS 900 mg prolonged-release suspension for injection
221611
Phase 3 small_molecule active
Quick answer
Vocabria 600 mg prolonged-release suspension for injection, REKAMBYS 900 mg prolonged-release suspension for injection for HIV Infections is a Phase 3 program (small_molecule) at ViiV Healthcare BV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ViiV Healthcare BV
- Indication
- HIV Infections
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active